Early work showed that the intra-cerebral injection of EPO was neuroprotective in a MPTP mouse model (Genc et al., 2001), a 6-hydroxydopamine mouse model (Signore et al., 2006), and a 6-hydroxydopamine rat model (Xue et al., 2007) of experimental PD. This evidence concerns the gene EPO and Parkinson disease.